Edwards Lifesciences Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Medical Specialties
ABTAbbott Laboratories 1.33%104.830.8%$766.88m
TMOThermo Fisher Scientific, Inc. 1.82%429.981.0%$634.03m
ISRGIntuitive Surgical, Inc. 2.93%693.442.4%$507.35m
MDTMedtronic Plc 1.44%104.650.6%$488.33m
DHRDanaher Corp. 1.25%209.750.7%$455.46m
BDXBecton, Dickinson & Co. 1.13%226.621.0%$426.78m
QDELQuidel Corp. 0.67%198.097.7%$406.16m
DXCMDexCom, Inc. -1.06%398.117.9%$315.72m
INOInovio Pharmaceuticals, Inc. -27.92%12.215.9%$299.95m
BSXBoston Scientific Corp. 2.79%38.381.0%$289.21m
SYKStryker Corp. 2.04%209.201.3%$288.33m
VARVarian Medical Systems, Inc. 0.01%172.009.1%$257.70m
BAXBaxter International, Inc. 0.85%80.321.8%$248.40m
ALGNAlign Technology, Inc. 1.76%323.536.4%$231.19m
EWEdwards Lifesciences Corp. 1.39%78.530.4%$229.15m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring system measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.